The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
γ-H2AX as a novel prognostic marker in patients with non-small lung cancer.
Dimitrios Matthaios
No relevant relationships to disclose
Panagiotis Hountis
No relevant relationships to disclose
Grigorios Trypsianis
No relevant relationships to disclose
Athanasios Zissimopoulos
No relevant relationships to disclose
Demosthenes Bouros
No relevant relationships to disclose
Petros Karakitsos
No relevant relationships to disclose
Stylianos Kakolyris
No relevant relationships to disclose